About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 535 record(s)
Req # A-2021-000412
Adverse Drug Reaction (ADR) for INFLUENZA VACCINE TRIVALENT. Report number: 000932398.Organization: Health Canada
July 2021
Req # A-2021-000413
Adverse Drug Reaction (ADR) for NFLUENZA VACCINE TRIVALENT. Report number: 000930942.Organization: Health Canada
July 2021
Req # A-2021-000444
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-100088-741, The New Dietary Guidelines for Americans (2020-2025).Organization: Health Canada
July 2021
Req # A-2021-000449
Adverse Reaction Reports (AERs). Report numbers: 000944125, 000940010.Organization: Health Canada
July 2021
Req # A-2021-000470
Adverse Drug Reaction (ADR). Report number: 000923900.Organization: Health Canada
July 2021
Req # A-2021-000473
Adverse Reaction Report (AER) for Naltrexone. Report number: 000938379. (AER) for Hydromorphone. Report number: 000939127.Organization: Health Canada
July 2021
Req # A-2021-000486
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-107376-390, 2019 Drug and Medical Device Highlights Report to be published on Health Canada's website May 28, 2020.Organization: Health Canada
July 2021
Req # A-2021-000501
Adverse Drug Reaction (ADR) for DEFLAZACORT. Report number: 000932035.Organization: Health Canada
July 2021
Req # A-2021-000504
Adverse Drug Reaction (ADR) for DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE. Report number: 000928924.Organization: Health Canada
July 2021
Req # A-2021-000505
Adverse Reaction Reports (AERs) for INFLUENZA VACCINE TRIVALENT. Report numbers: 000932950, 000933263, 000932310, 000932476, 000933463, 000930953, 000933351, 000929846.Organization: Health Canada
July 2021